Icon Cancer Foundation (ICF) is governed by a group of experts in research, medicine, business and finance.
Our Board of Directors makes sure the funds we raise are directed to vital research, while complying with legal and regulatory requirements.
All research and clinical trials undergo independent ethics committee assessment.
Dr Ramsay trained as a Radiation Oncologist in the UK before moving to a consultant post at Royal Brisbane Hospital and subsequently the Mater Hospital in Brisbane. His main clinical interests have been in breast, gynaecological and skin cancers. He has had a long-term interest in clinical and basic research having completed a Fellowship at Harvard Medical School and worked as a clinical scientist for four years at the University of Cambridge Department of Clinical Oncology.
He also held the position of Head of the QRI Laboratory in Translational Research at the Queensland Institute of Medical Research (QIMR) for 10 years and during this time completed a doctorate titled ‘Predicting the Response to Cancer Treatment’.
Dr Ramsay co-founded Radiation Oncology Queensland (ROQ), now Icon Cancer Centre, in 2005 which introduced a local radiation therapy service to Toowoomba in regional Queensland. This business grew exponentially with the opening of centres at the Gold Coast, Springfield, and Cairns before becoming the first radiation oncology business within Icon Group. Dr Ramsay was Director of Icon Group until 2017. He is also chair of the Radiation Therapy Advisory Group (RTAG) and Associate Professor at the University of Queensland.
He is also Icon Group’s Director of Research (radiation therapy and radiation medicine) where he leads the group’s radiation medicine clinical trial portfolio strategy and has a commitment to the application of clinical expertise to provide patient-centric care and greater access to clinical research.
BEcon, MCom, CA
Ross is Icon Group’s Global Director – Icon Cancer Centre and has more than 20 years’ experience in executive roles, including long-term Chief Financial Officer positions and 10 years’ experience in healthcare.
Ross’ focus and experience has seen Icon Group deliver on an ambitious growth strategy. He has overseen 20 acquisitions, including debt and equity financing to support the Group’s ongoing evolution in Australia and Asia. Ross has also previously led Finance, Information Technology and Facilities Support for Icon’s business divisions.
Ross is a chartered accountant and holds a Bachelor of Economics and Master of Commerce (Professional Accounting) from Macquarie University.
He has also been involved in a number of charities, including Telstra ChildFlight, The Victor Chang Cardiac Research Institute and Icon Cancer Foundation.
Sophie is Icon Group’s Executive Manager Research Global and has more than 25 years’ experience in medical, clinical and academic research. She has expertise in all aspects of oncology, haematology and theranostics clinical trial sites, from operational excellence, GCP compliance, quality management and clinical engagement.
Her strengths are in both building and transforming research programs and maximising research opportunities.
She is recognised as a national expert in trial management and strategic operations, with multiple engagements as a conference presenter and research educator across the Australian clinical trial sector. Her extensive experience in clinical trial leadership spans both the UK and Australia.
